Clinical Trial Update: "Unifuzol®" in Patients With Peripheral Arterial Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Unifuzol in patients with Peripheral Arterial Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Unifuzol

Snippet

Sponsor: POLYSAN Scientific & Technological Pharmaceutical Company | Conditions: Peripheral Arterial Disease | Phase 2 | Status: COMPLETED